Unknown

Dataset Information

0

Surgery for colorectal liver metastases: The evolution of determining prognosis.


ABSTRACT: Despite improvements in the multi-modality treatment of colorectal liver metastasis (CRLM), survival after resection remains varied. Determining prognosis after surgical resection has historically been predicated on preoperative clinicopathological factors such as primary tumor stage, carcinoembryonic antigen levels, number of liver metastases, presence of extrahepatic disease, as well as other factors. While scoring systems have been developed by combining certain preoperative factors, these have been inconsistent in accurately determining prognosis. There has been increasing interest in the use of biologic and molecular markers to predict prognosis following CRLM. The role of markers such as KRAS, BRAF, p53, human telomerase reverse transcriptase, thymidylate synthase, Ki-67, and hypoxia inducible factor-1? and their correlation with accurately predicting survival after surgical resection have been supported by several studies. Furthermore, other elements such as pathological response to chemotherapy and the presence of circulating tumor cells have shown promise in accurately determining prognosis after resection for colorectal liver metastasis. We herein review past, present, and possible future markers of prognosis among colorectal cancer patients with liver metastasis undergoing resection with curative intent.

SUBMITTER: Spolverato G 

PROVIDER: S-EPMC3868716 | biostudies-literature | 2013 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Surgery for colorectal liver metastases: The evolution of determining prognosis.

Spolverato Gaya G   Ejaz Aslam A   Azad Nilo N   Pawlik Timothy M TM  

World journal of gastrointestinal oncology 20131201 12


Despite improvements in the multi-modality treatment of colorectal liver metastasis (CRLM), survival after resection remains varied. Determining prognosis after surgical resection has historically been predicated on preoperative clinicopathological factors such as primary tumor stage, carcinoembryonic antigen levels, number of liver metastases, presence of extrahepatic disease, as well as other factors. While scoring systems have been developed by combining certain preoperative factors, these ha  ...[more]

Similar Datasets

| S-EPMC6583700 | biostudies-literature
| S-EPMC4999254 | biostudies-other
| S-EPMC5159720 | biostudies-literature
| PRJEB35154 | ENA
| S-EPMC7900034 | biostudies-literature
| S-EPMC7066250 | biostudies-literature
2022-12-01 | GSE207194 | GEO
| S-EPMC6125264 | biostudies-literature
| S-EPMC7447704 | biostudies-literature
| S-EPMC7452121 | biostudies-literature